NCT03911622

Brief Summary

To evaluate cesarean section scar and the lower uterine segment in non pregnant woman by MRI to :

  1. 1.Assess the clinical symptoms like postmenstrual spotting or prolonged menstrual bleeding, dysmenorrhea, chronic pelvic pain and dyspareunia and its relation to the presence of cesarean scar defects and its characteristics .
  2. 2.development of scoring system and correlating it with the symptoms .

Trial Health

35
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
30

participants targeted

Target at below P25 for all trials

Timeline
Completed

Started Apr 2019

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

April 7, 2019

Completed
4 days until next milestone

First Posted

Study publicly available on registry

April 11, 2019

Completed
19 days until next milestone

Study Start

First participant enrolled

April 30, 2019

Completed
1.3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 30, 2020

Completed
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

September 30, 2020

Completed
Last Updated

April 11, 2019

Status Verified

April 1, 2019

Enrollment Period

1.3 years

First QC Date

April 7, 2019

Last Update Submit

April 9, 2019

Conditions

Outcome Measures

Primary Outcomes (5)

  • MRI pelvis examination (sagittal T2WI ) using 1.5 tesla system Torso phased-array body coil with the patient in the supine position and a moderately full urinary bladder

    * Pre-designated standard protocols were followed consisting of T1-weighted (T1W) and T2-weighted (T2W) imaging sequences in axial and sagittal planes remaining perpendicular to the long axis of the scar * The scar site will be identified as the thinnest portion of LUS and having the lowest signal intensity on T2W imaging.

    baseline

  • MRI pelvis examination (sagittal T2WI ) using 1.5 tesla system Torso phased-array body coil with the patient in the supine position and a moderately full urinary bladder

    \- Scar position will be evaluated using relative distance in mm from inferior boundary of scar to external cervix os, which will be measured by curve distance in mm along the endometrium and cervical inner surface.

    baseline

  • MRI pelvis examination (sagittal T2WI ) using 1.5 tesla system Torso phased-array body coil with the patient in the supine position and a moderately full urinary bladder

    Scar thickness in mm will be calculated at the site of the scar .

    baseline

  • MRI pelvis examination (sagittal T2WI ) using 1.5 tesla system Torso phased-array body coil with the patient in the supine position and a moderately full urinary bladder

    Presence of endometrium adjacent to scar will be recorded

    baseline

  • MRI pelvis examination (sagittal T2WI ) using 1.5 tesla system Torso phased-array body coil with the patient in the supine position and a moderately full urinary bladder

    Scar shape were classified as "U" shape, "V" shape and mixed shape, judging from the transitional region from scar to normal uterine or cervical wal

    baseline

Secondary Outcomes (4)

  • clinical evaluation

    baseline

  • transabdominal and transvaginal ultrasound examination

    baseline

  • transabdominal and transvaginal ultrasound examination

    baseline

  • transabdominal and transvaginal ultrasound examination

    baseline

Interventions

MRIDEVICE

medical device that is used as an imaging tool for soft tissues

Eligibility Criteria

Age18 Years - 45 Years
Sexfemale
Healthy VolunteersNo
Age GroupsAdult (18-64)
Sampling MethodNon-Probability Sample
Study Population

Patients attending at out patient clinic complaining from abnormal bleat gynecology department at Assiut university hospitals

You may qualify if:

  • previous lower uterine segment cesarean section before .
  • At least 6 months after the last cesarean section .
  • still regularly menstruating .
  • Absence of other gynecological disease or intrauterine lesions like endometriosis , uterine fibroid .

You may not qualify if:

  • Post menopausal women .
  • hysterectomy .
  • Presence of other gynecological disease like endometriosis , uterine fibroids .
  • any general contraindication to MRI as presence of any paramagnetic substance as pacemakers or in severely ill patients or those with claustrophobia, arrhythmic patients .
  • intrauterine devices .
  • bleeding tendency.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Related Publications (7)

  • Jastrow N, Irion O, Roberge S, Bujold E. Clinical importance of appearance of cesarean hysterotomy scar at transvaginal ultrasonography in nonpregnant women. Obstet Gynecol. 2011 Jun;117(6):1438. doi: 10.1097/AOG.0b013e31821e24bc. No abstract available.

    PMID: 21606763BACKGROUND
  • Satpathy G, Kumar I, Matah M, Verma A. Comparative accuracy of magnetic resonance morphometry and sonography in assessment of post-cesarean uterine scar. Indian J Radiol Imaging. 2018 Apr-Jun;28(2):169-174. doi: 10.4103/ijri.IJRI_325_17.

    PMID: 30050239BACKGROUND
  • Hoffmann J, Stumpp P, Exner M, Grothoff M, Stepan H. Magnetic resonance imaging as additional diagnostic tool in assessment of lower uterine segment in women with previous Cesarean section. Ultrasound Obstet Gynecol. 2019 Feb;53(2):270-272. doi: 10.1002/uog.19046. No abstract available.

    PMID: 29532537BACKGROUND
  • Wong WSF, Fung WT. Magnetic Resonance Imaging in the Evaluation of Cesarean Scar Defect. Gynecol Minim Invasive Ther. 2018 Jul-Sep;7(3):104-107. doi: 10.4103/GMIT.GMIT_23_18. Epub 2018 Aug 23.

    PMID: 30254950BACKGROUND
  • Gonser M. Re: Prevalence, potential risk factors for development and symptoms related to the presence of uterine niches following Cesarean section: systematic review. Ultrasound Obstet Gynecol. 2014 Sep;44(3):371. doi: 10.1002/uog.14631. No abstract available.

    PMID: 25154489BACKGROUND
  • Pomorski M, Fuchs T, Zimmer M. Prediction of uterine dehiscence using ultrasonographic parameters of cesarean section scar in the nonpregnant uterus: a prospective observational study. BMC Pregnancy Childbirth. 2014 Oct 29;14:365. doi: 10.1186/s12884-014-0365-3.

    PMID: 25733122BACKGROUND
  • Kumar I, Verma A, Matah M, Satpathy G. Utility of multiparametric MRI in Caesarean section scar characterization and preoperative prediction of scar dehiscence: a prospective study. Acta Radiol. 2017 Jul;58(7):890-896. doi: 10.1177/0284185116675659. Epub 2016 Oct 31.

    PMID: 27799572BACKGROUND

Study Officials

  • Gehan Sayed, PHD

    Assiut University

    STUDY CHAIR
  • Omran Khodary, MD

    Assiut University

    STUDY DIRECTOR
  • Hisham Abou Taleb, MD

    Assiut University

    STUDY DIRECTOR

Central Study Contacts

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
resident doctor

Study Record Dates

First Submitted

April 7, 2019

First Posted

April 11, 2019

Study Start

April 30, 2019

Primary Completion

August 30, 2020

Study Completion

September 30, 2020

Last Updated

April 11, 2019

Record last verified: 2019-04